Circular RNAs (circRNAs) are stable, ring-shaped molecules that play crucial roles in brain development, cognition, and long-term cellular regulation.

Deep within our nerve cells, a molecule is at work that has no beginning and no end. Instead of a straight chain, as is ...

Cytosolic thiouridylase subunit 2 (CTU2) is an essential and conserved enzyme that modifies tRNA at the wobble position. However, the relationship between CTU2 expression and various cancer types ...

Contributed by Paul Schimmel, July 12, 2018 (sent for review April 25, 2018; reviewed by Michael Ibba and Andrew Weyrich) ...

Firefighters pour water into the roof of an abandoned structure, May 17. Photos by Rodney BardinAlamogordo NewsBalboafilms1999@yahoo.com Three Alamogordo Fire Department trucks responded to a fire ...

The contract also includes a favorable short-term cash structure and a no-trade clause, affirming the 49ers’ commitment to one of the modern NFL’s signature draft finds. We heard in late February ...

The FDA is prep­ping to rene­go­ti­ate its multi­bil­lion-dol­lar, quin­quen­ni­al user fee agree­ments with the drug in­dus­try lat­er this sum­mer, and a new deputy com­mis­sion ...

IT'S the kind of outcome which will perhaps surprise no-one with a long memory in Scottish football. But the news is just in after the SPFL's latest round of reconstruction talks - and what it ...

Micah McCartney is a reporter for Newsweek based in Taipei, Taiwan. He covers U.S.-China relations, East Asian and Southeast Asian security issues, and cross-strait ties between China and Taiwan.

Boston, Massachusetts--(Newsfile Corp. - May 15, 2025) - Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases ...

Board of Supervisors meeting, May 5. What happened: Jonathan Stoltzfus spoke on behalf of Isaac Lapp, arguing that an alleged historic structure Lapp removed may not have been historic ...

Boston, Massachusetts--(Newsfile Corp. - May 15, 2025) - Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, ...